Anti-erectile Dysfunction (ED) Drugs - Global and China Top Players Market Share and Ranking 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Anti-erectile Dysfunction (ED) Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Anti-erectile Dysfunction (ED) Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Anti-erectile Dysfunction (ED) Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital grew percent to account for percent of the total market sales, and Retail Pharmacy grew percent.
This report studies and analyses global Anti-erectile Dysfunction (ED) Drugs status and future trends, helps the client to determine the Anti-erectile Dysfunction (ED) Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Anti-erectile Dysfunction (ED) Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Anti-erectile Dysfunction (ED) Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Anti-erectile Dysfunction (ED) Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Anti-erectile Dysfunction (ED) Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Anti-erectile Dysfunction (ED) Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Anti-erectile Dysfunction (ED) Drugs key producing regions, capacity, production, and year over year growth
(6) Anti-erectile Dysfunction (ED) Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Vivus, Inc.
Lilly ICOS LLC
Pfizer
Bayer
Hims
Menarini Group
Lupin
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
General Factory
CSBio
Dong-A ST
Metuchen Pharma
Seoul Pharma
Teva Pharma
S.K. Chemicals
Market segment by Type, covers
Sildenafil (Viagra)
Vardenafil (Levitra, Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
Market segment by Application, can be divided into
Hospital
Retail Pharmacy
Clinic
Online Pharmacy
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Anti-erectile Dysfunction (ED) Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Anti-erectile Dysfunction (ED) Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Anti-erectile Dysfunction (ED) Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Anti-erectile Dysfunction (ED) Drugs, percent & CAGR, 2018-2029
Chapter 5: Anti-erectile Dysfunction (ED) Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Anti-erectile Dysfunction (ED) Drugs Definition
1.2 Global Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Anti-erectile Dysfunction (ED) Drugs Market Size，2019-2030
1.2.2 By Sales Quantity, Global Anti-erectile Dysfunction (ED) Drugs Market Size，2019-2030
1.2.3 Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP)，2019-2030
1.3 China Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Anti-erectile Dysfunction (ED) Drugs Market Size，2019-2030
1.3.2 By Sales Quantity, China Anti-erectile Dysfunction (ED) Drugs Market Size，2019-2030
1.3.3 China Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP)， 2019-2030
1.4 Share of China Anti-erectile Dysfunction (ED) Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Anti-erectile Dysfunction (ED) Drugs Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Anti-erectile Dysfunction (ED) Drugs Market Share in Global, 2019-2030
1.4.3 Anti-erectile Dysfunction (ED) Drugs Market Size: China VS Global, 2019-2030
1.5 Anti-erectile Dysfunction (ED) Drugs Market Dynamics
1.5.1 Anti-erectile Dysfunction (ED) Drugs Market Drivers
1.5.2 Anti-erectile Dysfunction (ED) Drugs Market Restraints
1.5.3 Anti-erectile Dysfunction (ED) Drugs Industry Trends
1.5.4 Anti-erectile Dysfunction (ED) Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Anti-erectile Dysfunction (ED) Drugs, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Anti-erectile Dysfunction (ED) Drugs, Global Market Share by Company, 2019-2024
2.3 Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Anti-erectile Dysfunction (ED) Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Anti-erectile Dysfunction (ED) Drugs Concentration Ratio
2.6 Global Anti-erectile Dysfunction (ED) Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Product Type
2.8 Head Office and Anti-erectile Dysfunction (ED) Drugs Production Site of Key Manufacturer
2.9 Anti-erectile Dysfunction (ED) Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Anti-erectile Dysfunction (ED) Drugs, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Anti-erectile Dysfunction (ED) Drugs, China Market Share by Company, 2019-2024
3.3 China Anti-erectile Dysfunction (ED) Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Anti-erectile Dysfunction (ED) Drugs Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Anti-erectile Dysfunction (ED) Drugs Capacity by Region
4.3 Global Anti-erectile Dysfunction (ED) Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Anti-erectile Dysfunction (ED) Drugs Production by Region, 2019-2030
4.5 Global Anti-erectile Dysfunction (ED) Drugs Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Anti-erectile Dysfunction (ED) Drugs Industry Chain
5.2 Anti-erectile Dysfunction (ED) Drugs Upstream Analysis
5.2.1 Anti-erectile Dysfunction (ED) Drugs Core Raw Materials
5.2.2 Main Manufacturers of Anti-erectile Dysfunction (ED) Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Anti-erectile Dysfunction (ED) Drugs Production Mode
5.6 Anti-erectile Dysfunction (ED) Drugs Procurement Model
5.7 Anti-erectile Dysfunction (ED) Drugs Industry Sales Model and Sales Channels
5.7.1 Anti-erectile Dysfunction (ED) Drugs Sales Model
5.7.2 Anti-erectile Dysfunction (ED) Drugs Typical Distributors
6 Sights by Type
6.1 Anti-erectile Dysfunction (ED) Drugs Classification
6.1.1 Sildenafil (Viagra)
6.1.2 Vardenafil (Levitra, Staxyn)
6.1.3 Tadalafil (Cialis)
6.1.4 Avanafil (Stendra)
6.1.5 Udenafil (Zydena)
6.1.6 Others
6.2 By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030
6.4 By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030
6.5 By Type, Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), 2019-2030
7 Sights by Application
7.1 Anti-erectile Dysfunction (ED) Drugs Segment by Application
7.1.1 Hospital
7.1.2 Retail Pharmacy
7.1.3 Clinic
7.1.4 Online Pharmacy
7.2 By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030
7.4 By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030
7.5 By Application, Global Anti-erectile Dysfunction (ED) Drugs Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030
8.3 By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Anti-erectile Dysfunction (ED) Drugs & Forecasts, 2019-2030
8.4.2 By Country, North America Anti-erectile Dysfunction (ED) Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Anti-erectile Dysfunction (ED) Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Anti-erectile Dysfunction (ED) Drugs Market Size Market Share
8.7 South America
8.7.1 South America Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Anti-erectile Dysfunction (ED) Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Anti-erectile Dysfunction (ED) Drugs Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030
9.3 By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.4.2 By Type, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.5.2 By Type, Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.6.2 By Type, China Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.7.2 By Type, Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.8.2 By Type, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.10.2 By Type, India Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Vivus, Inc.
10.1.1 Vivus, Inc. Company Information, Head Office, Market Area, and Industry Position
10.1.2 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Vivus, Inc. Company Profile and Main Business
10.1.5 Vivus, Inc. Recent Developments
10.2 Lilly ICOS LLC
10.2.1 Lilly ICOS LLC Company Information, Head Office, Market Area, and Industry Position
10.2.2 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Lilly ICOS LLC Company Profile and Main Business
10.2.5 Lilly ICOS LLC Recent Developments
10.3 Pfizer
10.3.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.3.2 Pfizer Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Pfizer Company Profile and Main Business
10.3.5 Pfizer Recent Developments
10.4 Bayer
10.4.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bayer Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Bayer Company Profile and Main Business
10.4.5 Bayer Recent Developments
10.5 Hims
10.5.1 Hims Company Information, Head Office, Market Area, and Industry Position
10.5.2 Hims Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Hims Company Profile and Main Business
10.5.5 Hims Recent Developments
10.6 Menarini Group
10.6.1 Menarini Group Company Information, Head Office, Market Area, and Industry Position
10.6.2 Menarini Group Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Menarini Group Company Profile and Main Business
10.6.5 Menarini Group Recent Developments
10.7 Lupin
10.7.1 Lupin Company Information, Head Office, Market Area, and Industry Position
10.7.2 Lupin Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Lupin Company Profile and Main Business
10.7.5 Lupin Recent Developments
10.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
10.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information, Head Office, Market Area, and Industry Position
10.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Profile and Main Business
10.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments
10.9 General Factory
10.9.1 General Factory Company Information, Head Office, Market Area, and Industry Position
10.9.2 General Factory Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.9.4 General Factory Company Profile and Main Business
10.9.5 General Factory Recent Developments
10.10 CSBio
10.10.1 CSBio Company Information, Head Office, Market Area, and Industry Position
10.10.2 CSBio Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.10.4 CSBio Company Profile and Main Business
10.10.5 CSBio Recent Developments
10.11 Dong-A ST
10.11.1 Dong-A ST Company Information, Head Office, Market Area, and Industry Position
10.11.2 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Dong-A ST Company Profile and Main Business
10.11.5 Dong-A ST Recent Developments
10.12 Metuchen Pharma
10.12.1 Metuchen Pharma Company Information, Head Office, Market Area, and Industry Position
10.12.2 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Metuchen Pharma Company Profile and Main Business
10.12.5 Metuchen Pharma Recent Developments
10.13 Seoul Pharma
10.13.1 Seoul Pharma Company Information, Head Office, Market Area, and Industry Position
10.13.2 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Seoul Pharma Company Profile and Main Business
10.13.5 Seoul Pharma Recent Developments
10.14 Teva Pharma
10.14.1 Teva Pharma Company Information, Head Office, Market Area, and Industry Position
10.14.2 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Teva Pharma Company Profile and Main Business
10.14.5 Teva Pharma Recent Developments
10.15 S.K. Chemicals
10.15.1 S.K. Chemicals Company Information, Head Office, Market Area, and Industry Position
10.15.2 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
10.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.15.4 S.K. Chemicals Company Profile and Main Business
10.15.5 S.K. Chemicals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Anti-erectile Dysfunction (ED) Drugs Market Restraints
Table 3. Anti-erectile Dysfunction (ED) Drugs Market Trends
Table 4. Anti-erectile Dysfunction (ED) Drugs Industry Policy
Table 5. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Anti-erectile Dysfunction (ED) Drugs Revenue Share by Company, 2019-2024, Ranked by Data of 2022
Table 7. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 9. Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)
Table 10. Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Anti-erectile Dysfunction (ED) Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Product Type
Table 13. Head Office and Anti-erectile Dysfunction (ED) Drugs Production Site of Key Manufacturer
Table 14. Anti-erectile Dysfunction (ED) Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China Anti-erectile Dysfunction (ED) Drugs Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 16. China Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 17. China Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 18. Global Anti-erectile Dysfunction (ED) Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 19. Global Anti-erectile Dysfunction (ED) Drugs Production by Region, 2019-2024, (K Units)
Table 20. Global Anti-erectile Dysfunction (ED) Drugs Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Anti-erectile Dysfunction (ED) Drugs Upstream (Raw Materials)
Table 22. Global Anti-erectile Dysfunction (ED) Drugs Typical Customers
Table 23. Anti-erectile Dysfunction (ED) Drugs Typical Distributors
Table 24. By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 25. By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 26. By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019 VS 2024 VS 2030, US$ Million
Table 27. By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030, US$ Million
Table 28. By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Table 29. By Country, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Country, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030, US$ Million
Table 31. By Country, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2019-2030
Table 32. By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Table 33. By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2019-2030
Table 34. Vivus, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 35. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 36. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 37. Vivus, Inc. Company Profile and Main Business
Table 38. Vivus, Inc. Recent Developments
Table 39. Lilly ICOS LLC Company Information, Head Office, Market Area, and Industry Position
Table 40. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 41. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Lilly ICOS LLC Company Profile and Main Business
Table 43. Lilly ICOS LLC Recent Developments
Table 44. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 45. Pfizer Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 46. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Pfizer Company Profile and Main Business
Table 48. Pfizer Recent Developments
Table 49. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 50. Bayer Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 51. Bayer Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Bayer Company Profile and Main Business
Table 53. Bayer Recent Developments
Table 54. Hims Company Information, Head Office, Market Area, and Industry Position
Table 55. Hims Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 56. Hims Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Hims Company Profile and Main Business
Table 58. Hims Recent Developments
Table 59. Menarini Group Company Information, Head Office, Market Area, and Industry Position
Table 60. Menarini Group Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 61. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Menarini Group Company Profile and Main Business
Table 63. Menarini Group Recent Developments
Table 64. Lupin Company Information, Head Office, Market Area, and Industry Position
Table 65. Lupin Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 66. Lupin Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Lupin Company Profile and Main Business
Table 68. Lupin Recent Developments
Table 69. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information, Head Office, Market Area, and Industry Position
Table 70. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 71. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Profile and Main Business
Table 73. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments
Table 74. General Factory Company Information, Head Office, Market Area, and Industry Position
Table 75. General Factory Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 76. General Factory Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. General Factory Company Profile and Main Business
Table 78. General Factory Recent Developments
Table 79. CSBio Company Information, Head Office, Market Area, and Industry Position
Table 80. CSBio Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 81. CSBio Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. CSBio Company Profile and Main Business
Table 83. CSBio Recent Developments
Table 84. Dong-A ST Company Information, Head Office, Market Area, and Industry Position
Table 85. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 86. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Dong-A ST Company Profile and Main Business
Table 88. Dong-A ST Recent Developments
Table 89. Metuchen Pharma Company Information, Head Office, Market Area, and Industry Position
Table 90. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 91. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Metuchen Pharma Company Profile and Main Business
Table 93. Metuchen Pharma Recent Developments
Table 94. Seoul Pharma Company Information, Head Office, Market Area, and Industry Position
Table 95. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 96. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Seoul Pharma Company Profile and Main Business
Table 98. Seoul Pharma Recent Developments
Table 99. Teva Pharma Company Information, Head Office, Market Area, and Industry Position
Table 100. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 101. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Teva Pharma Company Profile and Main Business
Table 103. Teva Pharma Recent Developments
Table 104. S.K. Chemicals Company Information, Head Office, Market Area, and Industry Position
Table 105. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application
Table 106. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. S.K. Chemicals Company Profile and Main Business
Table 108. S.K. Chemicals Recent Developments
List of Figures
Figure 1. Anti-erectile Dysfunction (ED) Drugs Picture
Figure 2. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, (US$ million) & (2019-2030)
Figure 3. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, (K Units) & (2019-2030)
Figure 4. Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), (2019-2030) & (US$/Unit)
Figure 5. China Anti-erectile Dysfunction (ED) Drugs Consumption Value, (US$ million) & (2019-2030)
Figure 6. China Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units) & (2019-2030)
Figure 7. China Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), (US$/Unit) & (2019-2030)
Figure 8. By Consumption Value, China Anti-erectile Dysfunction (ED) Drugs Market Share of Global, 2019-2030
Figure 9. By Sales Quantity, China Anti-erectile Dysfunction (ED) Drugs Market Share of Global, 2019-2030
Figure 10. Global Anti-erectile Dysfunction (ED) Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Anti-erectile Dysfunction (ED) Drugs Key Participants, Market Share, 2022
Figure 12. Global Anti-erectile Dysfunction (ED) Drugs Capacity, Production and Capacity Utilization, 2019-2030
Figure 13. Global Anti-erectile Dysfunction (ED) Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Anti-erectile Dysfunction (ED) Drugs Production Market Share & Forecast by Region, 2019-2030
Figure 15. Anti-erectile Dysfunction (ED) Drugs Industry Chain
Figure 16. Anti-erectile Dysfunction (ED) Drugs Procurement Model
Figure 17. Anti-erectile Dysfunction (ED) Drugs Sales Model
Figure 18. Anti-erectile Dysfunction (ED) Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Sildenafil (Viagra)
Figure 20. Vardenafil (Levitra, Staxyn)
Figure 21. Tadalafil (Cialis)
Figure 22. Avanafil (Stendra)
Figure 23. Udenafil (Zydena)
Figure 24. Others
Figure 25. By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030, US$ Million
Figure 26. By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2019-2030
Figure 27. By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 28. By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2019-2030
Figure 29. By Type, Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 30. Hospital
Figure 31. Retail Pharmacy
Figure 32. Clinic
Figure 33. Online Pharmacy
Figure 34. By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030, US$ Million
Figure 35. By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2019-2030
Figure 36. By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 37. By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2019-2030
Figure 38. By Application, Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 39. By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2019-2030
Figure 40. By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2019-2030
Figure 41. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 42. By Country, North America Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2022
Figure 43. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 44. By Country, Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2022
Figure 45. Asia Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 46. By Country/Region, Asia Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2022
Figure 47. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 48. By Country, South America Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2022
Figure 49. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 50. U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 51. By Type, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 53. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 54. By Type, Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 56. China Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 57. By Type, China Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, China Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 59. Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 60. By Type, Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 62. South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 63. By Type, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 65. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 66. By Type, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 68. India Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 69. By Type, India Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, India Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)
Figure 72. By Type, Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 73. By Application, Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 74. Research Methodology
Figure 75. Breakdown of Primary Interviews
Figure 76. Bottom-up and Top-down Approaches
Figure 77. Top-down Approaches
Research Methodology:
Anti-erectile Dysfunction (ED) Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|